CD19 chimeric antigen receptor T-cell therapy as a bridge therapy for allogeneic hematopoietic stem cell transplantation in patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia

被引：2
|
作者：
Yao, Zhenzhen [1 ]
Gu, Bin [1 ]
Zhang, Yanming [2 ,3 ]
Qi, Jiaqian [1 ]
Chen, Jia [1 ,4 ]
Xu, Yang [1 ,4 ,5 ]
Chen, Feng [1 ]
Ma, Xiao [1 ]
Miao, Miao [1 ]
Xue, Shengli [1 ,4 ]
Qiu, Huiying [1 ,4 ]
Tang, Xiaowen [1 ,4 ,5 ]
Han, Yue [1 ,4 ,5 ]
Chen, Suning [1 ,4 ,5 ]
Sun, Aining [1 ,4 ]
Yu, Lei [6 ]
Wu, Depei [1 ,4 ,5 ,7 ]
Wang, Ying [1 ,4 ,5 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Natl Clin Res Ctr Hematol Dis, Jiangsu Inst Hematol, Suzhou, Peoples R China
[2] Xuzhou Med Univ, Affiliated Huaian Hosp, Dept Hematol, 62 Huaihai Rd S, Huaian, Peoples R China
[3] Second Peoples Hosp Huaian, 62 Huaihai Rd S, Huaian, Peoples R China
[4] Soochow Univ, Inst Blood & Marrow Transplantat, Collaborat Innovat Ctr Hematol, Suzhou, Peoples R China
[5] Minist Hlth, Key Lab Thrombosis & Hemostasis, Suzhou, Peoples R China
[6] Shanghai Unicar Therapy Biomed Technol Co Ltd, Shanghai, Peoples R China
[7] Soochow Univ, State Key Lab Radiat Med & Protect, Suzhou, Peoples R China
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 01期
基金：
中国国家自然科学基金;
关键词：
CHEMOTHERAPY; CHILDREN; ADULTS;
D O I：
10.1038/s41409-022-01845-w
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：103 / 105
页数：3
相关论文
共 50 条
  • [1] CD19 chimeric antigen receptor T-cell therapy as a bridge therapy for allogeneic hematopoietic stem cell transplantation in patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia
    Zhenzhen Yao
    Bin Gu
    Yanming Zhang
    Jiaqian Qi
    Jia Chen
    Yang Xu
    Feng Chen
    Xiao Ma
    Miao Miao
    Shengli Xue
    Huiying Qiu
    Xiaowen Tang
    Yue Han
    Suning Chen
    Aining Sun
    Lei Yu
    Depei Wu
    Ying Wang
    Bone Marrow Transplantation, 2023, 58 : 103 - 105
  • [2] CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months
    Yao, Zhenzhen
    Gu, Bin
    Chen, Jia
    Xu, Yang
    Chen, Feng
    Xue, Shengli
    Qiu, Huiying
    Tang, Xiaowen
    Han, Yue
    Chen, Suning
    Sun, Aining
    Yu, Lei
    Zhang, Yanming
    Wu, Depei
    Wang, Ying
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [3] CD19 chimeric antigen receptor T-cell therapy in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia without complete molecular response at 3 months
    Zhenzhen Yao
    Bin Gu
    Jia Chen
    Yang Xu
    Feng Chen
    Shengli Xue
    Huiying Qiu
    Xiaowen Tang
    Yue Han
    Suning Chen
    Aining Sun
    Lei Yu
    Yanming Zhang
    Depei Wu
    Ying Wang
    Blood Cancer Journal, 13
  • [4] Chimeric antigen receptor T-cell therapy for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia and leukoencephalopathy who relapsed after bone marrow transplantation
    Kawabata, Naoko
    Hiramatsu, Hidefumi
    Mikami, Takashi
    Akazawa, Ryo
    Tanaka, Kuniaki
    Kouzuki, Kagehiro
    Kubota, Hirohito
    Saida, Satoshi
    Kato, Itaru
    Umeda, Katsutsugu
    Hirate, Tomoaki
    Kanda, Kaori
    Adachi, Souichi
    Takita, Junko
    PEDIATRIC BLOOD & CANCER, 2022, 69 (11)
  • [5] Allogeneic haematopoietic stem cell transplantation improves outcome of adults with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells
    Bin Gu
    Bing-Yu Shi
    Xiang Zhang
    Shi-Yuan Zhou
    Jian-Hong Chu
    Xiao-Jin Wu
    Cheng-Cheng Fu
    Hui-Ying Qiu
    Yue Han
    Su-Ning Chen
    Lei Yu
    Xiao Ma
    De-Pei Wu
    Bone Marrow Transplantation, 2021, 56 : 91 - 100
  • [6] Allogeneic haematopoietic stem cell transplantation improves outcome of adults with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells
    Gu, Bin
    Shi, Bing-Yu
    Zhang, Xiang
    Zhou, Shi-Yuan
    Chu, Jian-Hong
    Wu, Xiao-Jin
    Fu, Cheng-Cheng
    Qiu, Hui-Ying
    Han, Yue
    Chen, Su-Ning
    Yu, Lei
    Ma, Xiao
    Wu, De-Pei
    BONE MARROW TRANSPLANTATION, 2021, 56 (01) : 91 - 100
  • [7] Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation
    Chen, Yu-Hong
    Zhang, Xian
    Cheng, Yi-Fei
    Chen, Huan
    Mo, Xiao-Dong
    Yan, Chen-Hua
    Chen, Yao
    Han, Wei
    Sun, Yu-Qian
    Wang, Yu
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Liu, Kai-Yan
    Yang, Junfang
    Zhang, Jianping
    Zhang, Gai-Ling
    Shi, Yanze
    Su, Yun-Chao
    Li, Wen-Qian
    Xu, Li
    Song, Dan
    Zhang, Min
    Lu, Peihua
    Huang, Xiao-Jun
    CYTOTHERAPY, 2020, 22 (12) : 755 - 761
  • [8] Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Teng, Chieh-Lin Jerry
    Yu, Jui-Ting
    Chen, Hung-Chieh
    Hwang, Wen-Li
    ANNALS OF HEMATOLOGY, 2013, 92 (08) : 1137 - 1139
  • [9] Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Chieh-Lin Jerry Teng
    Jui-Ting Yu
    Hung-Chieh Chen
    Wen-Li Hwang
    Annals of Hematology, 2013, 92 : 1137 - 1139
  • [10] Anti-CD19 chimeric antigen receptor T-cell therapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia Two case reports
    Zhu, Yang-min
    Wu, Zhao
    Tan, You-ping
    Du, Yuan-yuan
    Liu, Zhi
    Ou, Rui-ming
    Liu, Shuang
    Pu, Cheng-fei
    Jiang, Jing
    Wang, Jin-ping
    Xiao, Lei
    Zhang, Qing
    MEDICINE, 2016, 95 (51) : e5676
12345